RBC Bioscience Corporation Stock Price

TPEX:6848 Community·NT$218.6m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

6848 Share Price Performance

NT$0

-17.95 (-100.00%)

NT$0

-17.95 (-100.00%)

NT$0

Fri, 2 Jan 26

Share Pricen/a

6848 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Acceptable track record with low risk.

3 Risks

1 Reward

View Full Analysis

RBC Bioscience Corporation Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: 1.51
: 48.03%
: 9.71%
: 167.1%

View Full Analysis

About 6848

Founded: 1995
Employees: 52
CEO: Mingwei Zhuo
WebsiteView website: www.rbcbioscience.com

RBC Bioscience Corporation researches, develops, manufactures, and sells reagents and devices for life science and molecular diagnosis in Europe, the United States, Asia, Taiwan, Africa, and Australia. It offers molecular biomedical diagnostic and research reagents, gene extraction automatic testing instruments, and gene extraction reagent tissues; automated nucleic acid extractors; and nucleic acid extraction kits. The company sells its products through distributors. RBC Bioscience Corporation was founded in 1995 and is based in New Taipei City, Taiwan.